Substituted oxazolidinones and their use

US8198267B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Swen Allerheiligen · Wuppertal, DE
• Marcus Bauser · Berlin, DE
• Hartmut Schirok · Wuppertal, DE
• Michael Härter · Wixom, US
• Stephan Siegel · Berlin, DE
• Ulrich Rester · Wuppertal, DE
• Christoph Gerdes
• Stefan Heitmeier · Wülfrath, DE
• Georges Von Degenfeld · Leverkusen, DE
• Anja Buchmüller · Essen, DE
• Elke Dittrich-Wengenroth · Wuppertal, DE
• Uwe Saatman · Wuppertal, DE
• Julia Strassburger · Wuppertal, DE
• Mark Jean Gnoth · Mettmann, DE
• Dieter Lang · Velbert, DE

Key dates

• Filing date: Jun 13, 2008
• Grant date: Jun 12, 2012
• Expiry date: Aug 5, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to novel substituted oxazolidinones, to processes for preparation thereof, to the use thereof for treatment and/or prophylaxis of diseases, and to the use thereof for producing medicaments for treatment and/or prophylaxis of diseases, especially of thromboembolic disorders.